- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Qtrex Quantum reports warrant exercises, clean capital structure | 2 | Investing.com | ||
| Mi | Qtrex Quantum meldet Ausübung von Optionsscheinen und bereinigte Kapitalstruktur | 2 | Investing.com Deutsch | ||
| Mi | QTREX Quantum Ltd.: QTREX Quantum Announces Clean Capital Structure | 3 | GlobeNewswire (USA) | ||
| 09.10. | QTREX receives Nasdaq non-compliance notice | 2 | Seeking Alpha | ||
| QTREX QUANTUM Aktie jetzt für 0€ handeln | |||||
| 09.10. | QTREX erhält Non-Compliance-Mitteilung der Nasdaq wegen Mindestkursanforderung | 5 | Investing.com Deutsch | ||
| 09.10. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 04.10. | Qtrex Quantum jumps 40% | 8 | Globes | ||
| 01.10. | QTREX Quantum Ltd.: QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader | 19 | GlobeNewswire (USA) | ||
| 25.09. | Inspira Technologies Oxy GAAP EPS of -$0.14 misses by $0.26, revenue of $1.55M | 4 | Seeking Alpha | ||
| 24.09. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 24.09. | QTREX Quantum Ltd H1 Loss Declines | 2 | RTTNews | ||
| 24.09. | QTREX Quantum Ltd.: QTREX Quantum Reports First Half 2026 Financial Results | 379 | GlobeNewswire (Europe) | Ness Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Record first half revenue of $1.55 million, up 438%, at a 61% gross margin, all generated by the AME and Quantum segment in its first 86 days... ► Artikel lesen | |
| 02.09. | QTREX Quantum Ltd.: One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology | 2 | GlobeNewswire (USA) | ||
| 31.08. | QTREX Quantum Ltd.: QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026 | 4 | GlobeNewswire (USA) | ||
| 28.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 7 | SEC Filings | ||
| 20.08. | QTREX Quantum nimmt 10 Millionen US-Dollar über Direktplatzierung ein | 6 | Investing.com Deutsch | ||
| 20.08. | QTREX Quantum Ltd.: QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares | 1 | GlobeNewswire (USA) | ||
| 19.08. | QTREX develops laser-printed carbon conductors for quantum chips | 4 | Investing.com | ||
| 19.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.08. | QTREX Quantum Ltd.: QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors | 1 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
81 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,168 | +2,34 % | Teladoc Health, Inc.: Teladoc Health to Announce Third Quarter 2026 Financial Results | ||
| SERNOVA BIOTHERAPEUTICS | 0,065 | -7,91 % | ALARM bei Sernova Biotherapeutics Inc: Folgt jetzt der nächste Kursrutsch? - Dringend handeln! | ||
| CERENOME | 1,576 | +12,73 % | Cerenome, Inc.: Cerenome Launches CNSide CSF Molecular Profile Tests | HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announced the commercial launch... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,240 | -13,85 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 15,100 | +4,14 % | Tandem Diabetes Care Q2 2026 Earnings Call Transcript | ||
| CO-DIAGNOSTICS | 0,652 | -0,38 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 12,715 | +10,66 % | QuidelOrtho Reports Q2 2026 Results: Full Earnings Call Transcript | ||
| VERU | 2,310 | +0,43 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,030 | +0,50 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,120 | +3,52 % | Why Is Clover Health (CLOV) Stock Soaring Today | ||
| SENSEONICS | 7,000 | +1,45 % | Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript | ||
| NANO-X IMAGING | 0,453 | -0,07 % | Nanox meldet vorläufigen Q3-Umsatz von bis zu $4,4 Millionen | ||
| TEMPEST THERAPEUTICS | 0,624 | 0,00 % | Tempest Therapeutics: Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise | ||
| IMUNON | 0,845 | +4,32 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |
Das Unternehmen QTREX QUANTUM LTD kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,010 (-0,67 %) liegt der Kurs bei 1,490 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QTREX QUANTUM LTD finden Sie auf Wallstreet Online.